Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world registry study of Taiji Huoxiang Zhengqi Oral Liquid
ChiCTR1800015077Phase 4Not yet recruiting
- Sponsor
- Hospital of Chengdu University of Traditional Chinese Medicine
- Start
- Mar 2018
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Huoxiang Zhengqi in nasopharyngitis, gastrointestinal conditions and summer dampness syndrome, sponsored by Hospital of Chengdu University of Traditional Chinese Medicine. Primary endpoints: Time to disease recovery and Time to disappearance of main symptom. Planned start Mar 2018; status: not yet recruiting.
02
Drugs
Huoxiang Zhengqi
03
Conditions
nasopharyngitisgastrointestinal conditionssummer dampness syndrome
Beyond the preview
Go deeper on ChiCTR1800015077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015077.